Eli Lillys claims against the online pharmacies allege importation of unapproved drug products containing tirzepatide along with misuse of the Mounjaro trademark and false and misleading statements regarding FDA approval and equivalency to the approval Mounjaro product
The pathophysiology of IC/BPS is poorly understood, and theories include chronic inflammation, autoimmune dysregulation, bacterial cystitis, urothelial dysfunction, deficiency of the glycosaminoglycan (GAG) barrier and urine cytotoxicity
Related Blog Posts Transforming Lives, One Step at a Time Keep reading Mons Pubis Fat Loss on GLP-1s: The Pubic Area Change Nobody Mentions One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone, How to Adjust Weight Loss Goals on GLP-1 Medications Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing
Apply a light amount directly to the scalp once a day (or once every other day)